Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Jiao He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1217-8589; OpenAlex author ID A5102842587. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 3

  1. Curbing Exosome Communications via Introducing Artificial Membrane Receptors for Metastatic Pancreatic Cancer Therapy. Co-author DOI 10.1002/adma.202303736↗
  2. Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles. Co-author DOI 10.1016/j.actbio.2021.05.002↗
  3. Glycaemic adverse drug reactions from anti-neoplastics used in treating pancreatic cancer. Co-author DOI 10.4103/njcp.njcp_444_16↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Man Li · 2 shared papers, 2021–2023 · strength 0.32
  2. Miao Deng · 1 shared paper, 2023 · strength 0.20
  3. Qin He · 1 shared paper, 2023 · strength 0.20
  4. Qianwen Yu · 1 shared paper, 2021 · strength 0.12
  5. Zhirong Zhang · 1 shared paper, 2021 · strength 0.12
  6. Qin He · 1 shared paper, 2021 · strength 0.12
  7. J Yan · 1 shared paper, 2017 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.